Harvey R. Kaslow, PhD

More complete information at USC Health Sciences Profiles:
https://profiles.sc-ctsi.org/harvey.kaslow
This URL can be obtained by searching Google for “Harvey Kaslow CTSI.”

Main research interest: Cancer Immunotherapy and Regulation of Immune Responses.
Cytotoxic antibodies and T lymphocytes can be generated that recognize cancer cells, but immunosuppressive factors in solid tumors frequently cause these effectors to fail to control or eliminate the cancer. Compositions are available that overcome these immunosuppressive factors but they produce toxic side-effects which can be life-threatening. There is thus a need for efficacious compositions and methods with reduced toxicity. In collaboration with the laboratory of Alan Epstein (Keck School of Medicine) candidate compositions and methods have been generated and more are under development. Patents covering some compositions and methods have issued and additional patent applications are ongoing and planned. See:
https://onedrive.live.com/view.aspx?resid=8981C17A0B407A86!39098&ithint=file%2cpptx&authkey=!ACYUwJ4HG0p1NRw

Education Efforts:
Dr. Kaslow’s graduate (UCSD) work involved endocrinology and metabolism and his post-doctoral (UCSF) research focused on cell signaling mechanisms. His teaching efforts continue in those areas in graduate, medical, and pharmacy courses. Dr. Kaslow serves as:
Director, MS program in Medical Physiology
Co-chair of the Endocrinology section of the medical student curriculum.
Dr. Kaslow actively participates in the continuing refinement and revision of the medical and graduate student curricula and is developing software for the analysis and management of the curriculum.

• Hamm-Alvarez, Sarah
• Akbari, Omid
• MacKay, John
• Longo, Valter
• Epstein, Alan
• Louie, Stanley